Skip Navigation LinksHome > September 2009 - Volume 17 - Issue 5 > Risk Factors for Quinolone-Resistant Escherichia coli Urinar...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e3181a4c728
Original Articles

Risk Factors for Quinolone-Resistant Escherichia coli Urinary Tract Infection

Vasquez, Gustavo A. MD*; Siu, Hugo R. MD†; Luna, Eduardo M. MD†; Reyes, Katherine C. MD*; Zervos, Marcus J. MD*‡

Collapse Box

Abstract

Background: Escherichia coli is the leading cause of urinary tract infections (UTI). Current Infectious Diseases Society of America (IDSA) guidelines recommend the use of fluoroquinolones when resistance to trimethoprim-sulfamethoxazole is greater than 10% to 20%. Identification of risk factors for fluoroquinolone-resistant E. coli may provide information to help in choosing the optimal empiric treatment of patients with UTI.

Objective: To identify risk factors for fluoroquinolone-resistant E. coli in patients with UTI.

Methods: Retrospective case control study of UTI caused by quinolone-resistant E. coli.

Results: Risk factors for fluoroquinolone-resistant E. coli UTI included recurrent UTI (odds ratio [OR], 2.28; P = 0.017), underlying medical disease (OR, 5.28; P < 0.001), urinary tract abnormalities (OR, 2.99; P = 0.002), prior hospitalization within the last 6 months (OR, 5.58; P = 0.032) and prior treatment with antibiotics within the last 6 months (OR, 13.72; P < 0.001). Isolates were susceptible to nitrofurantoin (94.9%), cepholosporins (79.7%), aminoglycosides (amikacin 97.5%, gentamicin 75.9%), and imipenem (98.7%).

Conclusions: Fluoroquinolones should be used with caution in patients with UTI and risk factors for fluoroquinolone-resistant E. coli.

© 2009 Lippincott Williams & Wilkins, Inc.